secwatch.observer — SEC 8-K summary
======================================

Issuer:     Doximity, Inc. (DOCS)
CIK:        0001516513
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001516513-22-000070
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Doximity Q1 FY2023 revenue $90.6M (+25% YoY); appoints Phoebe Yang to board
---------------------------------------------------------------------------

- Revenue $90.6M (+25% YoY); GAAP net income $22.4M (25% margin) vs $26.3M (36%) YoY.
- Adjusted EBITDA $33.5M (37% margin); non-GAAP diluted EPS $0.14 vs $0.11 YoY.
- Operating cash flow $44.8M (+35%); free cash flow $42.6M (+32%).
- Guidance: Q2 revenue $99.5-100.5M, adj. EBITDA $40-41M; FY2023 revenue $424-432M, adj. EBITDA $178-186M.
- Appointed Phoebe L. Yang (GM, AWS Healthcare) to board, replacing Gilbert Kliman; initial RSU grant $350K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516513/000151651322000070/0001516513-22-000070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516513/000151651322000070/docs-20220804.htm
  HTML page:      https://secwatch.observer/filing/0001516513-22-000070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer